Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock
-
Jon Yalmokas Joins Cantor Fitzgerald & Co. as Global Head of Prime Brokerage
-
Pre-Open Movers 10/02: (RIGL) (SNCR) (TRN) Higher; (JWN) (GNW) (ROKU) Lower (more...)
-
eHealth (EHTH): Raising PT To $27 Ahead Of Open Enrollment - Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Upgrades Zynerba Pharmaceuticals (ZYNE) to Overweight
-
Monarch Airlines goes bust, spoiling holiday plans for many Britons
-
GW Pharma (GWPH) Plenty of Room for Multiple AEDs - Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Visa (V) at Overweight
-
UPDATE: Cantor Fitzgerald Starts MasterCard (MA) at Overweight, Addition of ACH Capabilities is A Positive
-
Cantor Fitzgerald Says Valeant (VRX) Filing Disclosure Standard Operating Procedure, Unclear if Something Else Afoot
-
Intra-Cellular Therapies (ITCI) Prices 9.68M Share Common Offering at $15.50/Sh
-
Intra-Cellular Therapies Prices $150 Million Public Offering of Common Stock
-
AAC Holdings to Present at Cantor Fitzgerald Global Healthcare Conference
-
OncoSec to Present at the Cantor Fitzgerald Global Healthcare Conference
-
GTx Announces Webcast of Corporate Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
TherapeuticsMD (TXMD) Launches 12.4M Common Stock Offering
-
TherapeuticsMD Announces Public Offering of 12.4 Million Shares of Common Stock
-
Zoetis to Participate in the Cantor Fitzgerald Global Healthcare Conference
-
Arbutus to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Mesoblast Presents Corporate Updates at Global Healthcare Conferences
-
Freddie Mac Prices $464 Million Multifamily K-Deal, K-MP1, Backed by Properties Controlled by Morgan Properties
-
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
-
Curis to Present at the Cantor Fitzgerald Global Healthcare Conference
-
McEwen Mining Announces Closing of US$46.6 Million Bought Deal Offering
-
Pre-Open Movers 09/22: (ASND) (SVRA) (S) Higher; (VSAR) (ICPT) (FINL) Lower (more...)
-
Abeona Therapeutics Announces Upcoming Conference Participation
-
Acer Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York
-
Melinta Therapeutics to Participate in Two Upcoming Investor Conferences
-
Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Versartis (VSAR): VELOCITYAa Miss, But Potentially a Path Forward - Cantor
-
Verastem to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts Alibaba (BABA) at Overweight
-
CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
INSYS Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Assumes Agile Therapeutics (AGRX) at Overweight
-
Innoviva to Participate in Cantor Fitzgerald’s Global Healthcare Conference on September 26
-
Aldeyra Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Pulmatrix to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
-
Advaxis to Webcast Company Overview at the Cantor Fitzgerald Global Healthcare Conference
-
PolarityTE™ Announces Closing of $17.75 Million Above Market Private Placement
-
XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference
-
Savara to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference on September 27th
-
XBiotech to Present at Cantor Fitzgerald’s Global Healthcare Conference
-
Aptinyx to Present at Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
-
TG Therapeutics, Inc. to Present at Upcoming Investor Conferences
-
Wall Street pushed down by rate expectations, North Korea, Apple
-
ProQR to Present at Two Investor Conferences in September

